Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Collegium Pharma (COLL)

Collegium Pharma (COLL)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
26.79 +0.01 (+0.04%) 04/25/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 26.79 unch (unch) 16:01 ET
Quote Overview for Fri, Apr 25th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
26.22
Day High
27.09
Open 26.60
Previous Close 26.78 26.78
Volume 214,600 214,600
Avg Vol 397,960 397,960
Stochastic %K 60.24% 60.24%
Weighted Alpha -28.57 -28.57
5-Day Change -0.22 (-0.81%) -0.22 (-0.81%)
52-Week Range 23.23 - 42.29 23.23 - 42.29
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 904,194
  • Shares Outstanding, K 32,132
  • Annual Sales, $ 631,450 K
  • Annual Income, $ 69,190 K
  • EBIT $ 167 M
  • EBITDA $ 334 M
  • 60-Month Beta 0.76
  • Price/Sales 1.36
  • Price/Cash Flow 2.17
  • Price/Book 3.78

Options Overview Details

View History
  • Implied Volatility 73.60% ( -5.24%)
  • Historical Volatility 43.23%
  • IV Percentile 91%
  • IV Rank 81.92%
  • IV High 83.66% on 05/21/24
  • IV Low 27.97% on 09/20/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 4
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 368
  • Open Int (30-Day) 387

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.32
  • Number of Estimates 4
  • High Estimate 1.45
  • Low Estimate 1.20
  • Prior Year 1.32
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.23 +15.33%
on 04/10/25
Period Open: 30.15
30.52 -12.24%
on 04/01/25
-3.36 (-11.14%)
since 03/25/25
3-Month
23.23 +15.33%
on 04/10/25
Period Open: 32.59
34.06 -21.34%
on 01/28/25
-5.80 (-17.80%)
since 01/24/25
52-Week
23.23 +15.33%
on 04/10/25
Period Open: 35.84
42.29 -36.65%
on 10/07/24
-9.05 (-25.25%)
since 04/25/24

Most Recent Stories

More News
Collegium to Report First Quarter 2025 Financial Results on May 8, 2025

COLL : 26.79 (+0.04%)
2 Reasons to Watch COLL and 1 to Stay Cautious

2 Reasons to Watch COLL and 1 to Stay Cautious

COLL : 26.79 (+0.04%)
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

RPRX : 32.20 (+0.53%)
COLL : 26.79 (+0.04%)
SUPN : 32.22 (+2.78%)
OGN : 12.20 (+0.66%)
ZTS : 153.47 (+0.77%)
Collegium to Participate in 24th Annual Needham Virtual Healthcare Conference

COLL : 26.79 (+0.04%)
Collegium to Present Real-World Data at PainConnect 2025, the American Academy of Pain Medicine’s Annual Meeting

COLL : 26.79 (+0.04%)
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

BHVN : 19.84 (-15.21%)
COLL : 26.79 (+0.04%)
TRVI : 6.47 (+1.89%)
AVTX : 4.78 (-2.05%)
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

RPRX : 32.20 (+0.53%)
COLL : 26.79 (+0.04%)
SUPN : 32.22 (+2.78%)
OGN : 12.20 (+0.66%)
ZTS : 153.47 (+0.77%)
Collegium Announces Updates to its Board of Directors and Executive Leadership Team

COLL : 26.79 (+0.04%)
Collegium Announces Poster Presentations at the 2025 National Association of Pediatric Nurse Practitioners National Conference on Pediatric Health Care

COLL : 26.79 (+0.04%)
Collegium to Participate in Upcoming Investor Conferences

COLL : 26.79 (+0.04%)

Business Summary

Collegium Pharmaceutical Inc. is a specialty pharmaceutical company. It develops and commercializes prescription and over-the-counter pharmaceuticals for the treatment of central nervous system, respiratory and skin related disorders. The Company's product candidate consists of COL-195, COL-196, COL-171,...

See More

Key Turning Points

3rd Resistance Point 28.05
2nd Resistance Point 27.57
1st Resistance Point 27.18
Last Price 26.79
1st Support Level 26.31
2nd Support Level 25.83
3rd Support Level 25.44

See More

52-Week High 42.29
Fibonacci 61.8% 35.01
Fibonacci 50% 32.76
Fibonacci 38.2% 30.51
Last Price 26.79
52-Week Low 23.23

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective